ABBV-990 / AbbVie - LARVOL DELTA

Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants (clinicaltrials.gov) - P1 | N=24 | Terminated | Sponsor: AbbVie | N=40 ➔ 24 | Recruiting ➔ Terminated; Company decision: re-evaluation of risk vs benefit (based on animal data)

Adverse events • Enrollment change • Trial termination

Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants (clinicaltrials.gov) - P1 | N=40 | Recruiting | Sponsor: AbbVie

Adverse events • New P1 trial